A. SALMAN And E. CÖMERT, "The effectiveness and safety of higher doses of omalizumab in patients with chronic spontaneous urticaria: Real-life data from a retrospective cohort study," 24th World Congress of Dermatology , 2019
SALMAN, A. And CÖMERT, E. 2019. The effectiveness and safety of higher doses of omalizumab in patients with chronic spontaneous urticaria: Real-life data from a retrospective cohort study. 24th World Congress of Dermatology .
SALMAN, A., & CÖMERT, E., (2019). The effectiveness and safety of higher doses of omalizumab in patients with chronic spontaneous urticaria: Real-life data from a retrospective cohort study . 24th World Congress of Dermatology
SALMAN, ANDAÇ, And ELİF CÖMERT ÖZER. "The effectiveness and safety of higher doses of omalizumab in patients with chronic spontaneous urticaria: Real-life data from a retrospective cohort study," 24th World Congress of Dermatology, 2019
SALMAN, ANDAÇ And CÖMERT, ELİF C. . "The effectiveness and safety of higher doses of omalizumab in patients with chronic spontaneous urticaria: Real-life data from a retrospective cohort study." 24th World Congress of Dermatology , 2019
SALMAN, A. And CÖMERT, E. (2019) . "The effectiveness and safety of higher doses of omalizumab in patients with chronic spontaneous urticaria: Real-life data from a retrospective cohort study." 24th World Congress of Dermatology .
@conferencepaper{conferencepaper, author={ANDAÇ SALMAN And author={ELİF CÖMERT ÖZER}, title={The effectiveness and safety of higher doses of omalizumab in patients with chronic spontaneous urticaria: Real-life data from a retrospective cohort study}, congress name={24th World Congress of Dermatology}, city={}, country={}, year={2019}}